Clinical Trial Update: Mineralocorticoid Receptor Antagonist and Kidney Allograft Histology [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing a mineralocorticoid receptor antagonist and its effects on kidney allograft histology in patients with chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Snippet

Sponsor: Clinical Hospital Merkur | Conditions: Kidney Failure, Chronic | Phase 4 | Status: UNKNOWN